If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
affects |
not provided |
total |
362
|
113
|
1162
|
505
|
175
|
9
|
9
|
2283
|
Gene and significance breakdown #
Total genes and gene combinations: 26
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
affects |
not provided |
total |
LOC107303340, VHL
|
110
|
40
|
401
|
169
|
10
|
0 |
2
|
709
|
VHL
|
95
|
22
|
348
|
157
|
9
|
0 |
1
|
624
|
EGLN1
|
7
|
1
|
248
|
134
|
58
|
0 |
0 |
441
|
EPAS1
|
4
|
1
|
65
|
17
|
60
|
0 |
0 |
144
|
HBB, LOC106099062, LOC107133510
|
65
|
14
|
15
|
2
|
1
|
0 |
0 |
96
|
EPOR
|
0 |
0 |
22
|
9
|
23
|
7
|
5
|
61
|
HBB, LOC107133510, LOC110006319
|
23
|
6
|
14
|
1
|
0 |
0 |
0 |
44
|
HBA1, LOC106804613
|
21
|
13
|
0 |
0 |
0 |
0 |
0 |
33
|
HBA2, LOC106804612
|
16
|
13
|
3
|
0 |
1
|
0 |
0 |
33
|
EGLN1, LOC129932769
|
0 |
0 |
16
|
12
|
3
|
0 |
0 |
30
|
EPAS1, LOC129933655
|
0 |
0 |
9
|
1
|
3
|
0 |
0 |
13
|
INSL6, JAK2
|
1
|
2
|
5
|
1
|
1
|
1
|
1
|
10
|
EPAS1, LOC126806210
|
0 |
0 |
3
|
2
|
4
|
0 |
0 |
9
|
SH2B3
|
2
|
0 |
4
|
0 |
1
|
1
|
0 |
7
|
HBB, LOC106099062, LOC107133510, LOC110006319
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
BRK1, FANCD2, FANCD2OS, VHL
|
2
|
0 |
3
|
0 |
0 |
0 |
0 |
5
|
BRK1, FANCD2, FANCD2OS, LOC107303338, LOC107303339, LOC107303340, LOC129936148, LOC129936149, VHL
|
2
|
0 |
2
|
0 |
0 |
0 |
0 |
4
|
HBA1, HBA2, LOC106804612
|
2
|
0 |
1
|
0 |
0 |
0 |
0 |
3
|
EPO
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
EPOR, LOC130063571
|
0 |
0 |
1
|
0 |
1
|
0 |
0 |
2
|
FANCD2, VHL
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
ATM
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CEP120
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
EPAS1, LOC129933654
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
EPOR, LOC130063570
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
IRAK2, VHL
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
affects |
not provided |
total |
Labcorp Genetics (formerly Invitae), Labcorp
|
206
|
53
|
904
|
455
|
34
|
0 |
0 |
1652
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
179
|
38
|
143
|
0 |
0 |
360
|
Fulgent Genetics, Fulgent Genetics
|
83
|
51
|
124
|
12
|
3
|
0 |
0 |
273
|
Baylor Genetics
|
5
|
2
|
84
|
0 |
0 |
0 |
0 |
91
|
OMIM
|
73
|
0 |
0 |
0 |
0 |
9
|
0 |
81
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
|
0 |
1
|
2
|
7
|
6
|
0 |
0 |
16
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
|
5
|
5
|
4
|
1
|
0 |
0 |
0 |
15
|
Neuberg Centre For Genomic Medicine, NCGM
|
1
|
0 |
7
|
0 |
0 |
0 |
0 |
8
|
Juno Genomics, Hangzhou Juno Genomics, Inc
|
5
|
0 |
1
|
0 |
0 |
0 |
0 |
6
|
GeneReviews
|
0 |
0 |
0 |
0 |
0 |
0 |
5
|
5
|
Revvity Omics, Revvity
|
0 |
0 |
4
|
0 |
0 |
0 |
0 |
4
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust
|
1
|
0 |
1
|
1
|
0 |
0 |
0 |
3
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3
|
Mendelics
|
1
|
0 |
0 |
1
|
0 |
0 |
0 |
2
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Johns Hopkins Genomics, Johns Hopkins University
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
2
|
Unidade de Eritropatologia e Metabolismo do Ferro, Centro Hospitalar e Universitário de Coimbra
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
CSER _CC_NCGL, University of Washington
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
NIHR Bioresource Rare Diseases, University of Cambridge
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Center for Precision Medicine, Vanderbilt University Medical Center
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Cellular and Molecular Biology Laboratory, University of Campania Luigi Vanvitelli
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
University Health Network, Princess Margaret Cancer Centre
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
Lifecell International Pvt. Ltd
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Provincial Medical Genetics Program of British Columbia, University of British Columbia
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Molecular Diagnostics Laboratory, University of Rochester Medical Center
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.